Brandon Couillard
Stock Analyst at Wells Fargo
(4.54)
# 302
Out of 4,667 analysts
98
Total ratings
55.32%
Success rate
27.43%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,350 | $1,172.46 | +15.14% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $84 → $85 | $53.51 | +58.85% | 16 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Overweight | $78 → $75 | $54.35 | +37.99% | 2 | Nov 6, 2024 | |
| WAT Waters | Maintains: Overweight | $380 → $415 | $365.28 | +13.61% | 2 | Nov 4, 2024 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $34 → $75 | $73.38 | +2.21% | 2 | Oct 30, 2024 | |
| AVTR Avantor | Maintains: Overweight | $30 → $28 | $20.18 | +38.75% | 2 | Oct 28, 2024 | |
| TMO Thermo Fisher | Maintains: Overweight | $670 → $660 | $509.62 | +29.51% | 2 | Oct 24, 2024 | |
| A Agilent Technologies | Initiates: Overweight | $157 | $131.20 | +19.66% | 19 | Aug 27, 2024 | |
| MYGN Myriad Genetics | Initiates: Overweight | $35 | $15.37 | +127.72% | 1 | Aug 27, 2024 | |
| RGEN Repligen | Initiates: Overweight | $180 | $138.19 | +30.26% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $4.80 | +108.31% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $101.15 | +18.64% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $28 | $22.20 | +26.13% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $321.96 | +5.60% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $334.85 | +1.54% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $130 | $113.56 | +14.48% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $280 | $230.77 | +21.33% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $74 → $81 | $72.29 | +12.05% | 5 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $21.00 | +9.52% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.33 | +457.94% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $450 | $225.69 | +99.39% | 10 | Oct 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.86 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $4.46 | +146.64% | 2 | Oct 13, 2017 |
Mettler-Toledo International
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $1,400 → $1,350
Current: $1,172.46
Upside: +15.14%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $53.51
Upside: +58.85%
Bruker
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $75
Current: $54.35
Upside: +37.99%
Waters
Nov 4, 2024
Maintains: Overweight
Price Target: $380 → $415
Current: $365.28
Upside: +13.61%
GeneDx Holdings
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $73.38
Upside: +2.21%
Avantor
Oct 28, 2024
Maintains: Overweight
Price Target: $30 → $28
Current: $20.18
Upside: +38.75%
Thermo Fisher
Oct 24, 2024
Maintains: Overweight
Price Target: $670 → $660
Current: $509.62
Upside: +29.51%
Agilent Technologies
Aug 27, 2024
Initiates: Overweight
Price Target: $157
Current: $131.20
Upside: +19.66%
Myriad Genetics
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $15.37
Upside: +127.72%
Repligen
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $138.19
Upside: +30.26%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $4.80
Upside: +108.31%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $101.15
Upside: +18.64%
Aug 27, 2024
Initiates: Underweight
Price Target: $28
Current: $22.20
Upside: +26.13%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $321.96
Upside: +5.60%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $334.85
Upside: +1.54%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $130
Current: $113.56
Upside: +14.48%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $280
Current: $230.77
Upside: +21.33%
Mar 6, 2024
Maintains: Hold
Price Target: $74 → $81
Current: $72.29
Upside: +12.05%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $21.00
Upside: +9.52%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $2.33
Upside: +457.94%
Oct 22, 2020
Maintains: Buy
Price Target: $355 → $450
Current: $225.69
Upside: +99.39%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.86
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $4.46
Upside: +146.64%